Research Article
Identification of Protein Expression Changes in Hepatocellular Carcinoma through iTRAQ
Table 1
Patient demographic and clinical characteristics for iTRAQ and ELISA.
| | Characteristics | For iTRAQ | For ELISA | | Healthy controls () | HCC () | Healthy controls () | HCC () |
| | Gender | | | Male | 9 | 9 | 15 | 12 | | Female | 1 | 1 | 5 | 8 | | Age (years, ) | | | | | | Coexistences () | | | Hypertension | 2 | 1 | 4 | 2 | | Diabetes | 2 | 2 | 5 | 6 | | Smoking | 2 | 3 | 4 | 6 | | Drinking | 3 | 3 | 5 | 7 | | AFP (ng/ml, medians, IQR) | NA | 246.2 (7.4, 356.3) | NA | 15.54 (4.7, 255.3) | | Child-Pugh | | | A | NA | 4 | NA | 11 | | B | NA | 6 | NA | 9 | | Tumor size (mm, ) | NA | | NA | | | Differentiation degree | | | I–II | NA | 4 | NA | 6 | | II–III | NA | 5 | NA | 10 | | III–IV | NA | 1 | NA | 4 |
|
|
